Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2004 Apr 1;379(Pt 1):151–159. doi: 10.1042/BJ20030985

A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription.

Sarita Negi 1, Saurabh K Singh 1, Nirupma Pati 1, Vikas Handa 1, Ruchi Chauhan 1, Uttam Pati 1
PMCID: PMC1224047  PMID: 14680477

Abstract

The apo(a) [apolipoprotein(a)] gene is responsible for variations in plasma lipoprotein(a), high levels of which are a risk factor for atherosclerosis and myocardial infarction. The apo(a) promoter stimulates the expression of reporter genes in HepG2 cells, but not in HeLa cells. In the present study, we demonstrate that the 1.4 kb apo(a) promoter comprises two composite regulatory regions: a distal negative regulatory module (positions -1432 to -716) and a proximal tissue-specific module (-716 to -616). The distal negative regulatory module contains two strong negative regulatory regions [polymorphic PNR (pentanucleotide repeat region) and NREbeta (negative regulatory element beta)], which sandwich the postive regulatory region PREbeta (positive regulatory element beta). The PNR was shown to bind to transcription factors in a tissue-specific manner, whereas the ubiquitous transcription factors hepatocyte nuclear factor 3alpha and GATA binding protein 4 bound to NREbeta to repress gene transcription. The proximal tissue-specific module contains two regulatory elements: an activating region (PREalpha) that activates transcription in HepG2 cells, and NREalpha, which is responsible for repressing the apo(a) gene in HeLa cells. NREalpha binds to a HeLa-specific repressor. These multiple regulatory elements might work co-operatively to finely regulate apo(a) gene expression. Although the tissue-specific module is required for apo(a) gene activation and repression in a tissue-specific manner, the combinatorial interplay of the distal and proximal regulators might define the complex pathway(s) of apo(a) gene regulation.

Full Text

The Full Text of this article is available as a PDF (244.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andreani M., Olivier J. L., Berenbaum F., Raymondjean M., Béréziat G. Transcriptional regulation of inflammatory secreted phospholipases A(2). Biochim Biophys Acta. 2000 Oct 31;1488(1-2):149–158. doi: 10.1016/s1388-1981(00)00117-7. [DOI] [PubMed] [Google Scholar]
  2. Boerwinkle E., Leffert C. C., Lin J., Lackner C., Chiesa G., Hobbs H. H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992 Jul;90(1):52–60. doi: 10.1172/JCI115855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bossard P., Zaret K. S. GATA transcription factors as potentiators of gut endoderm differentiation. Development. 1998 Dec;125(24):4909–4917. doi: 10.1242/dev.125.24.4909. [DOI] [PubMed] [Google Scholar]
  4. Cao S. X., Gutman P. D., Dave H. P., Schechter A. N. Identification of a transcriptional silencer in the 5'-flanking region of the human epsilon-globin gene. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5306–5309. doi: 10.1073/pnas.86.14.5306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen Hui-Ju, Carr Kristie, Jerome Ronald E., Edenberg Howard J. A retroviral repetitive element confers tissue-specificity to the human alcohol dehydrogenase 1C (ADH1C) gene. DNA Cell Biol. 2002 Nov;21(11):793–801. doi: 10.1089/104454902320908441. [DOI] [PubMed] [Google Scholar]
  6. Christoffels V. M., Grange T., Kaestner K. H., Cole T. J., Darlington G. J., Croniger C. M., Lamers W. H. Glucocorticoid receptor, C/EBP, HNF3, and protein kinase A coordinately activate the glucocorticoid response unit of the carbamoylphosphate synthetase I gene. Mol Cell Biol. 1998 Nov;18(11):6305–6315. doi: 10.1128/mcb.18.11.6305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chuang S. S., Das H. K. Identification of trans-acting factors that interact with cis-acting elements present in the first nontranslated exon of the human apolipoprotein B gene. Biochem Biophys Res Commun. 1996 Mar 27;220(3):553–562. doi: 10.1006/bbrc.1996.0442. [DOI] [PubMed] [Google Scholar]
  8. Codlin Sandra, Soh Cecilia, Lee Tak, Lavender Paul. Characterization of a palindromic enhancer element in the promoters of IL4, IL5, and IL13 cytokine genes. J Allergy Clin Immunol. 2003 Apr;111(4):826–832. doi: 10.1067/mai.2003.1377. [DOI] [PubMed] [Google Scholar]
  9. Colantuoni V., Pirozzi A., Blance C., Cortese R. Negative control of liver-specific gene expression: cloned human retinol-binding protein gene is repressed in HeLa cells. EMBO J. 1987 Mar;6(3):631–636. doi: 10.1002/j.1460-2075.1987.tb04801.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. DeMeester C. A., Bu X., Gray R. J., Lusis A. J., Rotter J. I. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. Am J Hum Genet. 1995 Jan;56(1):287–293. [PMC free article] [PubMed] [Google Scholar]
  11. Delesque-Touchard N., Park S. H., Waxman D. J. Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. Proposed model for female specific expression of CYP2C12 in adult rat liver. J Biol Chem. 2000 Nov 3;275(44):34173–34182. doi: 10.1074/jbc.M004027200. [DOI] [PubMed] [Google Scholar]
  12. Denson L. A., McClure M. H., Bogue C. W., Karpen S. J., Jacobs H. C. HNF3beta and GATA-4 transactivate the liver-enriched homeobox gene, Hex. Gene. 2000 Apr 4;246(1-2):311–320. doi: 10.1016/s0378-1119(00)00082-2. [DOI] [PubMed] [Google Scholar]
  13. Dignam J. D. Preparation of extracts from higher eukaryotes. Methods Enzymol. 1990;182:194–203. doi: 10.1016/0076-6879(90)82017-v. [DOI] [PubMed] [Google Scholar]
  14. Gauthier Benoit R., Schwitzgebel Valerie M., Zaiko Maia, Mamin Aline, Ritz-Laser Beate, Philippe Jacques. Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements. Mol Endocrinol. 2002 Jan;16(1):170–183. doi: 10.1210/mend.16.1.0752. [DOI] [PubMed] [Google Scholar]
  15. Handa Vikas, Mahboob-ul-hussain, Pati Nirupma, Pati Uttam, ul-Hussain Mehboob. Multiple liver-specific factors bind to a 64-bp element and activate apo(a) gene. Biochem Biophys Res Commun. 2002 Mar 22;292(1):243–249. doi: 10.1006/bbrc.2002.6639. [DOI] [PubMed] [Google Scholar]
  16. Herbst R. S., Friedman N., Darnell J. E., Jr, Babiss L. E. Positive and negative regulatory elements in the mouse albumin enhancer. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1553–1557. doi: 10.1073/pnas.86.5.1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Huang Mei-Chuan, Li Kelly Ke, Spear Brett T. The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA). DNA Cell Biol. 2002 Aug;21(8):561–569. doi: 10.1089/104454902320308933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Huby T., Dachet C., Lawn R. M., Wickings J., Chapman M. J., Thillet J. Functional analysis of the chimpanzee and human apo(a) promoter sequences: identification of sequence variations responsible for elevated transcriptional activity in chimpanzee. J Biol Chem. 2001 Apr 11;276(25):22209–22214. doi: 10.1074/jbc.M102204200. [DOI] [PubMed] [Google Scholar]
  19. Ichinose A., Suzuki K., Takabatake N., Saito T. Multi-modal expression of apolipoprotein (a) gene in vivo. J Atheroscler Thromb. 1998;4(3):107–111. doi: 10.5551/jat1994.4.107. [DOI] [PubMed] [Google Scholar]
  20. Kagawa A., Azuma H., Akaike M., Kanagawa Y., Matsumoto T. Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription. J Biol Chem. 1999 Nov 26;274(48):34111–34115. doi: 10.1074/jbc.274.48.34111. [DOI] [PubMed] [Google Scholar]
  21. Kraus Jürgen, Börner Christine, Höllt Volker. Distinct palindromic extensions of the 5'-TTC...GAA-3' motif allow STAT6 binding in vivo. FASEB J. 2002 Dec 3;17(2):304–306. doi: 10.1096/fj.02-0482fje. [DOI] [PubMed] [Google Scholar]
  22. Kumar Meena S., Owens Gary K. Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol. 2003 Mar 6;23(5):737–747. doi: 10.1161/01.ATV.0000065197.07635.BA. [DOI] [PubMed] [Google Scholar]
  23. Kusakabe R., Kusakabe T., Suzuki N. In vivo analysis of two striated muscle actin promoters reveals combinations of multiple regulatory modules required for skeletal and cardiac muscle-specific gene expression. Int J Dev Biol. 1999 Sep;43(6):541–554. [PubMed] [Google Scholar]
  24. Laverriere A. C., MacNeill C., Mueller C., Poelmann R. E., Burch J. B., Evans T. GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J Biol Chem. 1994 Sep 16;269(37):23177–23184. [PubMed] [Google Scholar]
  25. Li-Weber M., Eder A., Krafft-Czepa H., Krammer P. H. T cell-specific negative regulation of transcription of the human cytokine IL-4. J Immunol. 1992 Mar 15;148(6):1913–1918. [PubMed] [Google Scholar]
  26. Li Shenyang, Dobretsova Anna, Kokorina Natalia A., Wight Patricia A. Repression of myelin proteolipid protein gene expression is mediated through both general and cell type-specific negative regulatory elements in nonexpressing cells. J Neurochem. 2002 Jul;82(1):159–171. doi: 10.1046/j.1471-4159.2002.00962.x. [DOI] [PubMed] [Google Scholar]
  27. Lindahl R., Xiao G. H., Falkner K. C., Prough R. A. Negative regulation of rat hepatic aldehyde dehydrogenase 3 by glucocorticoids. Adv Exp Med Biol. 1999;463:159–164. doi: 10.1007/978-1-4615-4735-8_19. [DOI] [PubMed] [Google Scholar]
  28. Lippi Giuseppe, Guidi Giancesare. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci. 2003 Feb;40(1):1–42. doi: 10.1080/713609328. [DOI] [PubMed] [Google Scholar]
  29. Miquerol L., Cluzeaud F., Porteu A., Alexandre Y., Vandewalle A., Kahn A. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions. Gene Expr. 1996;5(6):315–330. [PMC free article] [PubMed] [Google Scholar]
  30. Molkentin J. D., Lin Q., Duncan S. A., Olson E. N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997 Apr 15;11(8):1061–1072. doi: 10.1101/gad.11.8.1061. [DOI] [PubMed] [Google Scholar]
  31. Molkentin J. D. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem. 2000 Dec 15;275(50):38949–38952. doi: 10.1074/jbc.R000029200. [DOI] [PubMed] [Google Scholar]
  32. Murasawa S., Matsubara H., Mori Y., Kijima K., Maruyama K., Inada M. Identification of a negative cis-regulatory element and trans-acting protein that inhibit transcription of the angiotensin II type 1a receptor gene. J Biol Chem. 1995 Oct 13;270(41):24282–24286. doi: 10.1074/jbc.270.41.24282. [DOI] [PubMed] [Google Scholar]
  33. Overdier D. G., Porcella A., Costa R. H. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol. 1994 Apr;14(4):2755–2766. doi: 10.1128/mcb.14.4.2755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ramharack R., Wyborski R. J., Spahr M. A. The apolipoprotein(a) promoter contains a retinoid response element. Biochem Biophys Res Commun. 1998 Apr 7;245(1):194–197. doi: 10.1006/bbrc.1998.8398. [DOI] [PubMed] [Google Scholar]
  35. Remaley Alan T., Bark Samantha, Walts Avram D., Freeman Lita, Shulenin Sergey, Annilo Tarmo, Elgin Eric, Rhodes Hope E., Joyce Charles, Dean Michael. Comparative genome analysis of potential regulatory elements in the ABCG5-ABCG8 gene cluster. Biochem Biophys Res Commun. 2002 Jul 12;295(2):276–282. doi: 10.1016/s0006-291x(02)00652-6. [DOI] [PubMed] [Google Scholar]
  36. Røsby O., Berg K. LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level. J Intern Med. 2000 Jan;247(1):139–152. doi: 10.1046/j.1365-2796.2000.00628.x. [DOI] [PubMed] [Google Scholar]
  37. Samaras Susan E., Cissell Michelle A., Gerrish Kevin, Wright Christopher V. E., Gannon Maureen, Stein Roland. Conserved sequences in a tissue-specific regulatory region of the pdx-1 gene mediate transcription in Pancreatic beta cells: role for hepatocyte nuclear factor 3 beta and Pax6. Mol Cell Biol. 2002 Jul;22(13):4702–4713. doi: 10.1128/MCB.22.13.4702-4713.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Savagner P., Miyashita T., Yamada Y. Two silencers regulate the tissue-specific expression of the collagen II gene. J Biol Chem. 1990 Apr 25;265(12):6669–6674. [PubMed] [Google Scholar]
  39. Scanu A. M., Fless G. M. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest. 1990 Jun;85(6):1709–1715. doi: 10.1172/JCI114625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Song C. S., Jung M. H., Supakar P. C., Chatterjee B., Roy A. K. Negative regulation of the androgen receptor gene promoter by NFI and an adjacently located multiprotein-binding site. Mol Endocrinol. 1999 Sep;13(9):1487–1496. doi: 10.1210/mend.13.9.0350. [DOI] [PubMed] [Google Scholar]
  41. Suzuki K., Kuriyama M., Saito T., Ichinose A. Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region. J Clin Invest. 1997 Mar 15;99(6):1361–1366. doi: 10.1172/JCI119295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tanaka T., Uchiumi T., Hinoshita E., Inokuchi A., Toh S., Wada M., Takano H., Kohno K., Kuwano M. The human multidrug resistance protein 2 gene: functional characterization of the 5'-flanking region and expression in hepatic cells. Hepatology. 1999 Dec;30(6):1507–1512. doi: 10.1002/hep.510300617. [DOI] [PubMed] [Google Scholar]
  43. Wade D. P., Clarke J. G., Lindahl G. E., Liu A. C., Zysow B. R., Meer K., Schwartz K., Lawn R. M. 5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1369–1373. doi: 10.1073/pnas.90.4.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wade D. P., Lindahl G. E., Lawn R. M. Apolipoprotein(a) gene transcription is regulated by liver-enriched trans-acting factor hepatocyte nuclear factor 1 alpha. J Biol Chem. 1994 Aug 5;269(31):19757–19765. [PubMed] [Google Scholar]
  45. Werner T. Identification and functional modelling of DNA sequence elements of transcription. Brief Bioinform. 2000 Nov;1(4):372–380. doi: 10.1093/bib/1.4.372. [DOI] [PubMed] [Google Scholar]
  46. Wolfe S. A., Grimes S. R. Binding of nuclear proteins to an upstream element involved in transcriptional regulation of the testis-specific histone H1t gene. J Cell Biochem. 1999 Dec 15;75(4):555–565. doi: 10.1002/(sici)1097-4644(19991215)75:4<555::aid-jcb2>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES